Gaois

Search direction

Search mode

Filter results

Collections

17 results in 2 documents

  1. #2173834

    Rátaí arda mairfeachta agus mortlaíochta mortlaíocht laonna nuabheirthe, sin í an tsaintréith a bhaineann leis an heipitíteas eansótach i gcás an athchogantaigh clóis.

    RVF is characterised by high rates of abortion and neonatal mortality in domestic ruminants.

    Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (Text with EEA relevance)

  2. #2173846

    Níl saotharlann tagartha de chuid an Aontais Eorpaigh bunaithe ag an Aontas go fóill maidir leis an heipitíteas eansótach.

    So far, the Union has not established a European Union reference laboratory for RVF.

    Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (Text with EEA relevance)

  3. #2720217

    Iarscríbhinn VIII maidir le vacsaíniú in aghaidh ionfhabhtú le víreas fhiabhras Ghleann na Claise (RVF).

    Annex VIII on vaccination against infection with Rift Valley Fever virus (RVF).

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  4. #2720431

    Ionfhabhtú le víreas fhiabhras Ghleann na Claise (RVF)

    Infection with Rift valley fever virus (RVF)

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  5. #2720432

    COINNÍOLLACHA SONRACHA MAIDIR LE CUR CHUN FEIDHME VACSAÍNITHE PRÓIFIOLACSAIGH ÉIGEANDÁLA CHUN RVF A CHOSC AGUS A RIALÚ

    SPECIFIC CONDITIONS FOR THE IMPLEMENTATION OF EMERGENCY PROTECTIVE VACCINATION FOR PREVENTION AND CONTROL OF RVF

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  6. #2720447

    TRÉIMHSÍ ATHSHLÁNAITHE LE hAGHAIDH RVF

    RECOVERY PERIODS FOR RVF

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  7. #2173840

    Ina theannta sin, ghlac an tÚdarás Eorpach um Shábháilteacht Bia (EFSA) tuairim eolaíoch maidir leis an heipitíteas eansótach an 23 Eanáir 2020, tuairim inar cuireadh in iúl nár cheart neamhaird a thabhairt ar an mbaol go leathfadh an heipitíteas eansótach isteach i dtíortha atá i gcomharsanacht an Aontais ná ar an mbaol go dtabharfaí veicteoirí ionfhabhtaithe isteach san Aontas.

    In addition, the European Food Safety Authority (EFSA) adopted a scientific opinion on RVF on 23 January 2020, indicating that the risk of spread of RVF into countries neighbouring the Union and the risk of possible introduction of infected vectors into the Union should not be ignored.

    Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (Text with EEA relevance)

  8. #2173833

    An galar veicteoir-iompartha zónóiseach heipitíteas eansótach (RVF), galar a bhíonn ar an athchogantach fiáin agus ar an athchogantach clóis, is galar é atá ag teacht chun cinn, is víreas is cúis leis, agus d’fhéadfadh sé gur bagairt trasteorann a bheadh ann.

    Rift Valley fever (RVF) is an emerging zoonotic vector-borne disease of wild and domestic ruminants caused by a virus and representing a potential cross-border threat.

    Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (Text with EEA relevance)

  9. #2173836

    Tá an heipitíteas eansótach ar liosta na hEagraíochta Domhanda um Shláinte Ainmhithe (OIE) de ghalair ainmhíocha is gá a chur in iúl.

    RVF is on the list of notifiable animal diseases of the World Organisation for Animal Health (OIE).

    Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (Text with EEA relevance)

  10. #2173843

    Tá bearta leormhaithe um fhaireachas ar ghalar agus um chosc galair i bhfeidhm ag an Aontas i leith an heipitítis eansótaigh ionas gur cinnte go ndíothófar láithreach é má thagann sé isteach san Aontas.

    The Union has in place adequate surveillance and disease control measures against RVF to ensure its immediate eradication if the disease enters into the Union.

    Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (Text with EEA relevance)

  11. #2173848

    Dá bhrí sin, ba cheart saotharlann tagartha de chuid an Aontais Eorpaigh maidir leis an heipitíteas eansótach a bhunú leis an Rialachán seo, saotharlann a rannchuideodh le héifeachtacht rialuithe oifigiúla a áirithiú agus le cúnamh do shaotharlanna oifigiúla a chomhordú,

    This Regulation should therefore establish a European Union reference laboratory for RVF to contribute to ensure the effectiveness of official controls and to coordinate assistance to official laboratories,

    Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (Text with EEA relevance)

  12. #2720439

    COINNÍOLLACHA SONRACHA MAIDIR LE FAIREACHAS TREISITHE CLINICIÚIL AGUS SAOTHARLAINNE ATÁ LE CUR CHUN FEIDHME SNA CRIOSANNA VACSAÍNITHE AGUS PEIREA-VACSAÍNITHE LE LINN VACSAÍNIÚ PRÓIFIOLACSACH ÉIGEANDÁLA CHUN RVF A CHOSC AGUS A RIALÚ

    SPECIFIC CONDITIONS FOR THE REINFORCED CLINICAL AND LABORATORY SURVEILLANCE TO BE IMPLEMENTED IN THE VACCINATION AND PERI-VACCINATION ZONES DURING EMERGENCY PROTECTIVE VACCINATION FOR PREVENTION AND CONTROL OF RVF

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  13. #2173837

    I Márta 2019, d’fhoilsigh an Lárionad Eorpach um Ghalair a Chosc agus a Rialú (ECDC) mear-mheasúnú riosca chun aghaidh a thabhairt ar an mbaol a bhí ann go dtiocfadh víreas an heipitítis eansótaigh thar tír isteach agus go scaipfeadh sé a thuilleadh laistigh den Aontas agus den Limistéar Eorpach Eacnamaíoch (LEE) i bhfianaise an mhéadaithe ar chásanna a tuairiscíodh in Mayotte.

    In March 2019, the European Centre for Disease Prevention and Control (ECDC) published a rapid risk assessment to address the risk of importation of RVF virus and further spread of the virus within the Union and the European Economic Area (EEA) in relation to the increase in cases reported in Mayotte.

    Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (Text with EEA relevance)

  14. #2173838

    Is éard a tugadh chun suntais sa mheasúnú sin, cé gur baol an-bheag don Aontas agus do LEE a bhí sna ráigeanna sin ó thaobh víreas an heipitítis eansótaigh a thabhairt isteach trí thrádáil dhleathach na n-ainmhithe agus na dtáirgí ainmhíocha, is rud a bhféadfadh baol a bheith ag baint leis atá in iompar mídhleathach na feola úire, an bhainne neamhphaistéaraithe agus táirgí neamhchóireáilte de thionscnamh cogantaigh a bhfuil an víreas orthu.

    The assessment highlighted that, although the risk from these outbreaks was very low for the Union and the EEA in terms of introduction of RVF virus through the legal trade of animals and animal products, the illegal transport of fresh meat, unpasteurised milk and untreated products from infected ruminants in personal luggage could pose a risk.

    Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (Text with EEA relevance)

  15. #2173841

    An baol atá ann go dtiocfadh an heipitíteas eansótach isteach san Aontas, is rud é a fhágann gur cheart don Aontas bearta leordhóthanacha faireachais agus rialaithe i gcoinne an ghalair sin a bhunú, rud atá i gcomhréir le Rialachán (AE) 2016/429 ó Pharlaimint na hEorpa agus ón gComhairle lena mbunaítear creat reachtach um chosc agus rialú galar liostaithe.

    The risk of RVF entering the Union means that the Union should establish adequate surveillance and control measures against this disease, in accordance with Regulation (EU) 2016/429 of the European Parliament and of the Council, which establishes a legislative framework for the prevention and control of listed diseases.

    Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (Text with EEA relevance)

  16. #2173842

    I gcomhréir leis an Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) 2018/1882 ón gCoimisiún, meastar gur galar de na catagóirí A, D agus E atá sa heipitíteas eansótach, agus gur gá a luaithe a bhraitear é dul i muinín bearta díothaithe ina leith.

    In accordance with the Annex to Commission Implementing Regulation (EU) 2018/1882, RVF is considered as a category A, D and E disease, for which immediate eradication measures are to be taken as soon as it is detected.

    Commission Delegated Regulation (EU) 2021/2156 of 17 September 2021 supplementing Regulation (EU) 2017/625 of the European Parliament and of the Council by establishing the European Union reference laboratory for Rift Valley fever (Text with EEA relevance)

  17. #2720441

    COINNÍOLLACHA SONRACHA MAIDIR LE GLUAISEACHTAÍ AINMHITHE AGUS TÁIRGÍ A THOIRMEASC AGUS MAIDIR LE MAOLÚ A DHEONÚ I gCOMHRÉIR LE hAIRTEAGAL 13, I gCRIOS VACSAÍNITHE INA nDÉANTAR VACSAÍNIÚ PRÓIFIOLACSACH ÉIGEANDÁLA CHUN RVF A CHOSC AGUS A RIALÚ

    SPECIFIC CONDITIONS FOR THE PROHIBITION OF MOVEMENTS OF ANIMALS AND PRODUCTS AND FOR GRANTING A DEROGATION IN ACCORDANCE WITH ARTICLE 13, IN A VACCINATION ZONE WHERE EMERGENCY PROTECTIVE VACCINATION FOR PREVENTION AND CONTROL OF RVF IS CARRIED OUT

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)